Bacterial Infections Could be ‘Sniffed Out’ With New Tech
Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.
Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.
The QuickMIC system aims to improve sepsis care by enabling faster, more accurate antibiotic treatment decisions.
AI-based antimicrobial susceptibility test method promises rapid prediction of antimicrobial resistance using blood of sepsis patients.
A recent review of advances in pediatric sepsis biomarkers provides an overview of research advancements across various omics levels.
Read MoreResearchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read MoreThe Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read MoreCytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read MoreInflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read MoreSiemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
Read MoreThe test system is intended to be used in emergency department settings in patients with suspected acute infection and sepsis.
Read MoreSteripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MoreResearch from the Penn State College of Health and Human Development found that a new blood test for sepsis could save lives and money.
Read MoreT2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read MoreT2 Biosystems praised actions taken by the CDC aimed at optimizing hospital sepsis programs in the United States.
Read MoreCDC Director Mandy Cohen, MD, MPH, is set to release guidelines that offer a roadmap for hospitals to reduce deaths from sepsis.
Read MoreA diagnostic tool that detects sepsis in patients in under 10 minutes is now in use at Our Lady of the Lake Regional Medical Center.
Read MoreCytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.Â
Read MoreDelay in sepsis diagnosis increases the risk of dying by 8% every hour; and can lead to the unnecessary use of strong antibiotic therapies.
Read More